BiPRO GmbH, Research Institute for Integrated Solutions, Grauertstr. 12, 81545 Munich, Germany.
Int J Hyg Environ Health. 2012 Feb;215(2):172-5. doi: 10.1016/j.ijheh.2011.08.010. Epub 2011 Sep 21.
Human biomonitoring (HBM) can be an effective tool to assess human exposure to environmental pollutants and potential health effects and is increasingly seen as an essential element in a strategy when integrating health and environment. HBM can be used (i) to prioritise actions and measures for policy making; (ii) to evaluate policy actions aimed at reducing exposure to potentially hazardous environmental stressors; and (iii) to promote more comprehensive health impact assessments of policy options. In support of the European Environment and Health Action Plan 2004-2010, European scientists, experts from authorities and other stakeholders joined forces to work towards developing a functional framework and standards for a coherent HBM in Europe. Within the European coordination action on human biomonitoring, 35 partners from 27 European countries in the COPHES consortium aggregated their experiences and expertise and developed harmonized approaches and recommendations for better comparability of HBM data in Europe via the elaboration of a harmonized study protocol. This protocol is the product of discussion and compromises on the selection of environmental exposures, national environmental health concerns, and political and health priorities. The harmonised approach includes sampling recruitment, and analytical procedures, communication strategies and biobanking initiatives. The protocols and the harmonised approach are a means to increase acceptance and policy support and to in the future to enable determination of time trends. The common pilot study protocol will shortly be tested, adapted and assessed in the framework of the DEMOCOPHES in 17 European countries, including 16 EU Member States. COPHES and DEMOCOPHES constitute important steps towards establishing human biomonitoring as a tool for EU environmental and health policy and to improve quantification of exposure of the general European population to existing and emerging pollutants.
人体生物监测(HBM)可以作为评估人类暴露于环境污染物和潜在健康影响的有效工具,并且越来越被视为整合健康与环境策略的重要组成部分。HBM 可以用于:(i) 为政策制定确定优先行动和措施;(ii) 评估旨在减少潜在有害环境应激物暴露的政策行动;以及 (iii) 促进对政策选择的更全面健康影响评估。为支持欧洲环境与健康行动计划 2004-2010,欧洲科学家、当局专家和其他利益攸关方联手合作,努力为欧洲建立一个连贯的 HBM 功能框架和标准。在欧洲人类生物监测协调行动中,来自 27 个欧洲国家的 35 个合作伙伴,在 COPHES 联盟中汇聚了他们的经验和专业知识,通过制定协调一致的研究方案,为改善欧洲 HBM 数据的可比性制定了协调一致的方法和建议。该方案是对环境暴露、国家环境卫生问题以及政治和健康优先事项的选择进行讨论和妥协的产物。协调方法包括抽样招聘、分析程序、沟通策略和生物库倡议。该方案和协调方法是提高认可度和政策支持的手段,并将在未来确定时间趋势。共同的试点研究方案将很快在包括 16 个欧盟成员国在内的 17 个欧洲国家的 DEMOCOPHES 框架内进行测试、调整和评估。COPHES 和 DEMOCOPHES 是将人体生物监测作为欧盟环境与健康政策工具的重要步骤,旨在提高对现有和新兴污染物的欧洲普通人群暴露的量化水平。